Halozyme Therapeutics reported $142K in Ordinary Share Capital for its second fiscal quarter of 2021.


Ok
Trading Economics members can view, download and compare data from nearly 200 countries, including more than 20 million economic indicators, exchange rates, government bond yields, stock indexes and commodity prices.

The Trading Economics Application Programming Interface (API) provides direct access to our data. It allows API clients to download millions of rows of historical data, to query our real-time economic calendar, subscribe to updates and receive quotes for currencies, commodities, stocks and bonds.

Please Paste this Code in your Website
width
height
Ordinary Share Capital Change
Acadia Pharmaceuticals ACAD:US $ 0.02M 0M
Agios Pharmaceuticals AGIO:US $ 0.07M 0M
Alnylam Pharmaceuticals ALNY:US $ 1.19M 0.01M
Amarin AMRN:US $ 292.78M 0.42M
Amgen AMGN:US $ 31877M 71M
Aptinyx Inc APTX:US $ 677K 8K
Arena Pharmaceuticals ARNA:US $ 0.01M 0M
Baxter International BAX:US $ 683M 0M
Cara Therapeutics CARA:US $ 50K 0
Cytokinetics CYTK:US $ 0.07M 0M
Eli Lilly And LLY:US $ 598.1M 1.6M
Esperion Therapeutics ESPR:US $ 26K 0
Halozyme Therapeutics HALO:US $ 0.14M 0M
Immunogen IMGN:US $ 2M 0M
Intercept Pharmaceuticals ICPT:US $ 0.03M 0M
Intra Cellular Therapies ITCI:US $ 0.01M 0M
Intrexon XON:US $ 0M 0M
IONIS PHARMACEUT IONS:US $ 0.14M 0M
JAZZ PHA JAZZ:US $ 0.06M 0M
Mannkind MNKD:US $ 2.5M 0M
Minerva Neurosciences NERV:US $ 0M 0M
Nektar Therapeutics NKTR:US $ 0.02M 0M
Peregrine Pharmaceuticals PPHM:US $ 0.06M 0M
Rigel Pharmaceuticals RIGL:US $ 0.17M 0M
United Therapeutics UTHR:US $ 0.7M 0M
Vanda Pharmaceuticals VNDA:US $ 0.06M 0M